CorMedix (CRMD) Research Hub

CorMedix (CRMD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 7.94 USD (+1.15%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 3.34, market cap 0.62B. This hub links to the full technical, earnings and options research available for CRMD.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close7.94 USD (+1.15%)
52-week range7.06 USD – 9.06 USD
Trend regimeRange
14-day RSI69.4 (Bullish)
Trailing P/E3.34
Market cap0.62B
Dividend yield0.00%
Next earnings2026-08-06

Available research for CRMD

Earnings

CRMD earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E 3.34. Updated 2026-07-23.

Options: Covered Call

Covered Call on CRMD: how it works, illustrative setup around the real 7.94 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on CRMD: how it works, illustrative setup around the real 7.94 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on CRMD: how it works, illustrative setup around the real 7.94 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

CRMD technical analysis: range, last 7.94 USD, RSI 69.4, 52w range 7.06 USD–9.06 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is CRMD in?

CorMedix (CRMD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is CRMD in an uptrend or downtrend?

As of 2026-10-26, CRMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is CRMD's trailing P/E ratio?

CRMD's trailing P/E is 3.34, with a market cap of 0.62B. See the earnings research page for full valuation detail.

When does CRMD next report earnings?

CRMD is next scheduled to report earnings on 2026-08-06.